Table 2.
Prediction analysis of microarray (PAM) classification of samples based on miRNA expression. Training was performed on all samples except the single HGD using 10-fold internal cross validation. The HGD sample classification was then predicted based on the training analysis but is forced into one of the histologies used in the training. Adenocarcinoma, AC; squamous cell carcinoma, SCC; normal squamous epithelium, NSE; Barrett’s esophagus (BE); High grade dysplasia (HGD).
| Histology | Number of samples | PAM Classification
|
|||
|---|---|---|---|---|---|
| AC | SCC | NSE | BE | ||
| AC | 10 | 10 | 0 | 0 | 0 |
| SCC | 10 | 0 | 10 | 0 | 0 |
| NSE | 9 | 0 | 1 | 7 | 1 |
| BE | 5 | 1 | 0 | 1 | 3 |
| HGD | 1 | 1 | 0 | 0 | 0 |